Leprosy as a genetic model for susceptibility to common infectious diseases

Human Genetics

Volumn 123, Issue 3, 2008, Pages 227-235

  Alter, Andrea ^a,b   Alcaïs, Alexandre ^c,d   Abel, Laurent ^c,d   Schurr, Erwin ^a,b,e  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE; GENE PRODUCT; LYMPHOTOXIN ALPHA PROTEIN; PARKIN; PROTEIN PACRG; PROTEIN PARK2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

BACTERIUM IDENTIFICATION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HEREDITY; HUMAN; INFECTION; LEPROSY; LINKAGE ANALYSIS; MOLECULAR CLONING; MYCOBACTERIUM LEPRAE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIET NAM;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEPROSY; MODELS, GENETIC; MOLECULAR CHAPERONES; MYCOBACTERIUM LEPRAE; UBIQUITIN-PROTEIN LIGASES;

MYCOBACTERIUM LEPRAE;

EID: 41149087158     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-008-0474-z     Document Type: Review

References (44)

1. Abel L, Demenais F (1988) Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade island. Am J Hum Genetics 42:256-266
2. Abel L, Vu D, Oberti J, Nguyen V, Van V, Guilloud-Bataille M, Schurr E, Lagrange P (1995) Complex segregation analysis of leprosy in southern Vietnam. Genetic Epidemiol 12:63-82
3. Alcais A, Alter A, Antoni G, Orlova M, Van Thuc N, Singh M, Vanderborght PR, Katoch K, Mira MT, Thai VH, Huong NT, Ba NN, Moraes M, Mehra N, Schurr E, Abel L (2007) Stepwise replication identifies a low-producing lymphotoxin-[alpha] allele as a major risk factor for early-onset leprosy. Nat Genet 39:517-522
4. Alcais A, Mira M, Casanova J-L, Schurr E, Abel L (2005) Genetic dissection of immunity in leprosy. Curr Opin Immunol 17:44-48
5. Ali S, Vollaard A, Widjaja S, Surjadi C, van de Vosse E, van Dissel J (2006) PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever. Clin Exp Immunol 144:425-431
6. Britton WJ, Lockwood DNJ (2004) Leprosy. Lancet 363:1209-1219
7. Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S, Jaeger E, Vijayakrishnan J, Kemp Z, Gorman M, Chandler I, Papaemmanuil E, Penegar S, Wood W, Sellick G, Qureshi M, Teixeira A, Domingo E, Barclay E, Martin L, Sieber O, Kerr D, Gray R, Peto J, Cazier J-B, Tomlinson I, Houlston RS (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39:1315-1317
8. Casrouge A, Zhang S-Y, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Senechal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Heron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova J-L (2006) Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency. Science 314:308-312
9. Chakravartti M, Vogel F (1973) A twin study on leprosy. In: Becker PE, Lenz W, Vogel F, Wendt GG (eds) Topics in human genetics, vol 1. Georg Thieme, Stuttgart, pp 1-123
10. Chaudhury S, Hazra S, Saha B, Mazumder B, Biswas P, Chattopadhya D, Saha K (1994) An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis. Int J Lepr Other Mycobact Dis 62:389-394
11. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honore N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG (2001) Massive gene decay in the leprosy bacillus. Nature 409:1007-1011
12. Convit J, Sampson C, Zuniga M, Plata J, Silva J, Molina J, Pinardi ME, Salgado A, Smith PG, Bloom BR (1992) Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: Preliminary results. The Lancet 339:446-450
13. Eiglmeier K, Fsihi H, Heym B, Cole ST (1997) On the catalase-peroxidase gene, katG, of Mycobacterium leprae and the implications for treatment of leprosy with isoniazid. FEMS Microbiol Lett 149:273-278
14. Fernando SL, Britton WJ (2006) Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol 84:125-137
15. Fitness J, Tosh J, Hill AVS (2002) Genetics of susceptibility to leprosy. Genes Immunol 3:441-453
16. Gupte M, Vallishayee R, Anantharaman D, Nagaraju B, Sreevatsa., Balasubramanyam S, de Britto R, Elango N, Uthayakumaran N, Mahalingam V, Lourdusamy G, Ramalingam A, Kannan S, Arokiasamy J (1998) Comparative leprosy vaccine trial in south India. Indian J Lepr 70:369-388
17. Hyun D, Lee M, Hattori N, Kubo S, Mizuno Y, Halliwell B, Jenner P (2002) Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J Biol Chem 277:28572-28577
18. Knight JC, Keating BJ, Kwiatkowski DP (2004) Allele-specific repression of lymphotoxin-[alpha] by activated B cell factor-1. Nat Genet 36:394-399
19. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J (2007) Variation in interleukin 7 receptor [alpha] chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39:1108-1113
20. Malhotra D, Darvishi K, Lohra M, Kumar H, Grover C, Sood S, Reddy BSN, Bamezai RNK (2005) Association study of major risk single nucleotide polymorphisms in the common regulatory region of PARK2 and PACRG genes with leprosy in an Indian population. Eur J Hum Genet 14:438-442
21. Marmor MF (2002) The ophthalmic trials of G. H. A. Hansen. Surv Ophthalmol 47:275-287
22. Miller EN, Jamieson SE, Joberty C, Fakiola M, Hudson D, Peacock CS, Cordell HJ, Shaw MA, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM (2004) Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun 5:63-67
23. Mira MT (2006) Genetic host resistance and susceptibility to leprosy. Microbes Infect 8:1124-1131
24. Mira MT, Alcais A, Van Thuc N, Moraes MO, Di Flumeri C, Hong Thai V, Chi Phuong M, Thu Huong N, Ngoc Ba N, Xuan Khoa P, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Dore C, Gallant CJ, Lepage P, Verner A, van de Vosse E, Hudson TJ, Abel L, Schurr E (2004) Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427:636-640
25. Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, Ba NN, Verner A, Hudson TJ, Abel L, Schurr E (2003) Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 33:412-415
26. Monot M, Honore N, Garnier T, Araoz R, Coppee J-Y, Lacroix C, Sow S, Spencer JS, Truman RW, Williams DL, Gelber R, Virmond M, Flageul B, Cho S-N, Ji B, Paniz-Mondolfi A, Convit J, Young S, Fine PE, Rasolofo V, Brennan PJ, Cole ST (2005) On the origin of leprosy. Science 308:1040-1042
27. Pandya S (1998) Anti-contagionism in leprosy, 1844-1897. Int J Lepr Other Mycobact Dis 66:374-384
28. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, Khawaja SA, Bagnall R, Burke DA, Todhunter CE, Ahmad T, Onnie CM, McArdle W, Strachan D, Bethel G, Bryan C, Lewis CM, Deloukas P, Forbes A, Sanderson J, Jewell DP, Satsangi J, Mansfield JC, Cardon L, Mathew CG (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39:830-832
29. Ridley D, Jopling W (1966) Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34:255-273
30. Roach D, Briscoe H, Saunders B, Britton W (2005) Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection. Infect Immunity 73:4787-4792
31. Roach DR, Briscoe H, Saunders B, France MP, Riminton S, Britton WJ (2001) Secreted lymphotoxin-{{alpha}} is essential for the control of an intracellular bacterial infection. J Exp Med 193:239-246
32. Schurr E, Alcais A, de Leseleuc L, Abel L (2006) Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. Semin Immunol 18:404-410
33. Shaw M, Donaldson I, Collins A, Peacock C, Lins-Lainson Z, Shaw J, Ramos F, Silveira F, Blackwell J (2001) Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun. 2:196-204
34. Shepard CC (1960) The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J Exp Med 112:445-454
35. Shields E, Russell D, Pericak-Vance MA (1987) Genetic epidemiology of the susceptibility to leprosy. J Clin Invest 79:1139-1143
36. Siddiqui MR, Meisner S, Tosh K, Balakrishnan K, Ghei S, Fisher SE, Golding M, Shanker Narayan NP, Sitaraman T, Sengupta U, Pitchappan R, Hill AVS (2001) A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 27:439-441
37. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885
38. Soslash;rensen T, Nielsen G, Andersen P, Teasdale T (1988) Genetic and environmental influences on premature death in adult adoptees. New Engl J Med 318:727-732
39. Tosh K, Meisner S, Siddiqui M, Balakrishnan K, Ghei S, Golding M, Sengupta U, Pitchappan R, Hill A (2002) A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J Infectious Dis 186:1190-1193
40. Vanderborght PR, Pacheco AG, Moraes ME, Antoni G, Romero M, Verville A, Thai VH, Huong NT, Ba NN, Schurr E, Sarno EN, Moraes MO (2007) HLA-DRB1[ast]04 and DRB1[ast]10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun 8:320-324
41. WHO (2007) Global leprosy situation, 2007. Weekly Epidemiol Record 82:225-232
42. Zerva L, Cizman B, Mehra NK, Alahari SK, Murali R, Zmijewski CM, Kamoun M, Monos DS (1996) Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J Exp Med 183:829-836
43. Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku C-L, Casrouge A, Zhang X-X, Barreiro L, Leonard J, Hamilton C, Lebon P, Heron B, Vallee L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova J-L (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527
44. Zondervan KT, Cardon LR (2007) Designing candidate gene and genome-wide case-control association studies. Nat Protocols 2:2492-2501